Participants List from Academia
Untitled Document
University of Texas at Arlington, USA
Stanford University School of Medicine, USA
Mahidol University, Thailand
Amirkabir University of Technology, Iran
Hamdard University, India
Yeshiva University, USA
University of Macau, China
Monash University, Australia
University of Michigan, Ann Arbor
Universidade Federal do Rio de Janeiro, Brazil
University of Denver, Colorado
University of Toronto, Canada
Zagazig University, Egypt
Banaras Hindu University, India
Taipei Medical University, Taiwan
University di Messina CNISM, Italy
University of Tasmania, Australia
Huazhong University of Science and Technology, China
Sogang University, Korea
University of Edinburgh, UK
Martin-Luther-University Halle-Wittenberg, USA
Universidade de Sao Paulo, Brazil
Eve University, Turkey
University of Delhi, India
Isfahan University of Technology(IUT), Iran
Taif University, Saudi Arabia
University Medical Center, Netherlands
University of Copenhagen, Denmark
University Paris 13, France
Participants List from Business
Untitled Document
Cadila Pharmaceuticals, India
Chemical Works of Gedeon Richter, Hungary
3S-Pharmacological Consultation & Research GmbH, Germany
Royal Brisbane and Women's Hospital, Australia
Psoriasis and Cutaneous Inflammation Research Laboratory, USA
Alcon Laboratories Inc., USA
National Institute for Materials Science (NIMS), Japan
Grup de Recerca de Reumatologia (IRHVH), Spain
Bayer Health Care, Richmond, USA
Crown Bioscience Inc., China
Hammersmith Hospital, London
Van Drie Research LLC, USA
Dr.Reddy's labs, India
Merck Research Laboratories, USA
National Institute of Pharmaceutical Education and Research (NIPER), India
AstraZeneca R&D Boston, USA
Abbott Laboratories, USA
Hutchison MediPharma Limited, China
Sage Bionetworks, USA
Central Drug Research Institute, India
Glenmark Pharmaceuticals, India
National Institute for Interdisciplinary Science & Technology (NIIST) , India
Novartis Campus, Austria
Upcoming Conferences
2nd World Congress on Cell Science & Stem Cell Research, will be organized around the theme "Recent Innovations and Technologies in Stem Cell Research".
Cell Science-2012 is comprised of 11 tracks and 56 sessions designed to offer comprehensive sessions that address current issues in Cell Science & Stem Cell Research .
Submit your abstract to any of the following tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Executive Editors
Ming Pei
West Virginia University, USA
Hiroshi Kobayashi
Chiba University, Japan
David T. Harris
University of Arizona, USA
Lee Buckler
Cell Therapy Group,, USA
Diana Anderson
University of Bradford, UK
Jing-Gung Chung
China Medical University, Republic of China
Qiaoxiang Dong
University of Texas Health Science Center, USA
Shahriar Yaghoubi
UCLA School of Medicine, USA
Fei Li
New York University, USA
Amir Hamdi
University of Texas MD Anderson Cancer Center, USA
Irina Burd
Johns Hopkins University School of Medicine, USA
Theodore P. Rasmussen
University of Connecticut, USA
Jed Johnson
Nanofiber Solutions, USA
Maryam Niapour
Adisave, Canada
Hendarto H,
University of Airlangga Surabaya, Indonesia
Shimon Slavin
International Center for Cell Therapy & Cancer Immunotherapy (CTCI), Israel
Joseph Larkin
University of Florida, USA
Lily Huang
University of Texas Southwestern Medical Center, USA
Gene P. Siegal
University of Alabama, USA
Oleksandr Kukharchuk
A.A. Shalimov AMS, Ukraine
Richard G. Pestell
Kimmel Cancer Center, USA
Ratna K Vadlamudi
University of Texas, USA
Marxa L. Figueiredo
University of Texas, USA
Haval Shirwan
University of Louisville, USA
Morayma Reyes
University of Washington, USA
Theodore P. Rasmussen
University of Connecticut, USA
Shahriar Yaghoubi
UCLA School of Medicine, USA
Jed Johnson
Nanofiber Solutions, USA
Xinghua Pan
Yale University, USA
Jatawa S K
Rajiv Gandhi Proudyogiki Vishwavidyalatya, India
Madhulika Dixit
Indian Institute of Technology, India
Track 1 : Stem Cell Therapy
Track 1-1
Cell-based immunotherapy with mesenchymal stem cells
Track 1-2
Cell replacement therapy for diabetes
Track 1-3
Stem cell therapy of neurological disorders
Track 1-4
Repairing our heart and muscles
Track 1-5
Development of stem cell therapy for the treatment of retinal degeneration
Track 2 : Cancer Cell Therapy
Track 2-1
Designing novel cancer therapy
Track 2-2
Lung cancer: progress in diagnosis, staging and therapy
Track 2-3
Human malignancies and potential therapy for cancer
Track 2-4
Cell therapy: clinical trials
Track 2-5
Inflammatory diseases and cancer
Track 2-6
Cancer stem cells
Track 3 : Stem-Cell Transplantation
Track 3-1
Hematopoietic stem cell transplantation
Track 3-2
Transplantation immunology: solid organ and bone marrow
Track 3-3
Overcoming the barriers to umbilical cord blood transplantation
Track 3-4
Chemotherapy with autologous stem cell transplantation
Track 4 : Tissue Engineering
Track 4-1
Cartilage tissue engineering
Track 4-2
Angiogenesis & vascular tissue engineering
Track 4-3
Tissue engineering & regenerative medicine
Track 4-4
Recent advances in tissue engineering
Track 4-5
Biomedical engineering
Track 5 : Cell Science & Development
Track 5-1
Cell signaling pathways & apoptosis
Track 5-2
Molecular cell growth & proliferation
Track 5-3
Cytokines
Track 5-4
T- Cell and B-Cell biology
Track 5-5
Cell dynamics and migration
Track 6 : Advances in Gene & Stem Cell Therapy
Track 6-1
Human gene therapy (Human Genome Project), genetic screening & DNA testing
Track 6-2
Cell therapy approaches for lung diseases
Track 6-3
Moving forward with cystic fibrosis gene therapy
Track 6-4
Gene therapy: somatic & germline
Track 6-5
Gene therapy for immunodeficiency
Track 6-6
Cell therapy for diabetes
Track 6-7
Gene therapy for heart failure
Track 7 : Organ Specific Stem Cells
Track 7-1
Breast cancer stem cells
Track 7-2
Neural stem cells
Track 7-3
Mouse & human embryonic stem cells
Track 7-4
Bone marrow stem cells
Track 7-5
Hair follicle stem cells
Track 8 : Stem Cell Medicine: Social and Political Challenges
Track 8-1
Personalized medicine and stem cells health
Track 8-2
The future of regenerative medicine
Track 8-3
The pharmacy of the future: cells, not pills
Track 8-4
Stem cell research and ethical issues
Track 8-5
Current laws and policies surrounding stem cell research
Track 8-6
Challenges and obstacles in stem cell research
Track 9 : Pluripotency and Differentiation
Track 9-1
Chromatin changes during reprogramming to pluripotency
Track 9-2
Systematic analysis of genome regulatory and their regulation
Track 9-3
Polycomb repression co-associates with non-productive RNA polymerase II in ES cells
Track 9-4
Novel sources for pluripotent stem cells
Track 10 : Regulation of Stem Cells
Track 10-1
Regulation of hydroxymethylcytosine marked genes in embryonic stem cells
Track 10-2
Regulation of skeletal muscle stem cells during development and regeneration
Track 10-3
Self renewal and regulation of WNT signals for cell fate determination
Track 10-4
Extrinsic regulators of epidermal stem cell fate dormancy
Track 10-5
Molecular pathways and mechanisms of stem cell regulation
Track 10-6
Regulation of stem cell quiescence and proliferation
Track 11 : Epigenetic Reprogramming
Track 11-1
Epigenetic reprogramming in mammalian development
Track 11-2
Epigenetic reprogramming of somatic cells towards pluripotency
Track 11-3
The histone demethylase LSD1/KDM1 maintains stem cell fates by reprogramming epigenetic memory